Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Sees Large Decrease in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a significant decrease in short interest in November. As of November 30th, there was short interest totalling 13,000 shares, a decrease of 15.6% from the November 15th total of 15,400 shares. Based on an average daily volume of 22,000 shares, the short-interest ratio is currently 0.6 days.

Cardio Diagnostics Stock Performance

Shares of NASDAQ CDIOW traded up $0.02 during mid-day trading on Monday, reaching $0.13. 170,102 shares of the company traded hands, compared to its average volume of 27,737. The company’s fifty day moving average is $0.04 and its two-hundred day moving average is $0.04. Cardio Diagnostics has a fifty-two week low of $0.02 and a fifty-two week high of $0.28.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.